BAB V KESIMPULAN DAN SARAN
5.2 Saran
Berdasarkan kesimpulan di atas disusulkan agar dilakukannya :
a) Kelemahan penelitian ini belum membahas berdasarkan kelompok komplikasi sehingga perlu untuk dikaji kembali.
b) penelitian prospektif terkait dosis metadon dengan jangka waktu pengamatan yang lebih panjang.
DAFTAR PUSTAKA
Annies, NI. (2014). Evaluasi Program Terapi Rumatan Metadon Bagi Pecandu Heroin di Puskesmas Kecamatan Tebet. UIN Jakarta.
Association of Southeast Asian Nations (ASEAN) – USAID. (2007). Managing Opioid Dependence: Treatment and Care for HIV Positive Injecting Drug Users, Jakarta: ASEAN Secretariat
Badan Narkotika Nasional (2010) 3,6 Juta Warga Indonesia Gunakan Narkoba. Http://www.BNN.go.id
Badan Narkotika Nasional Republik Indonesia. (2006). Pedoman Pencegahan Penyalahgunaan Narkoba Bagi Pemuda. Jakarta
Badan Narkotika Nasional Republik Indonesia. (2004). Pedoman Pencegahan Penyalahgunaan Narkoba Bagi Pemuda. Jakarta.
Ball JC, Lange WR, Myers CP, Friedman SR. (1988). Reducing the risk of AIDS through methadone maintenance treatment. Harwood academic publisher:
Amsterdam.
Bell,J dan Zador,D. (2000). A risk-benefit Analysis of methadone maintenance treatment. [Abstract]. Drug Saf: 22(3): 179-190.
Birkitt, DJ, (1999). Drug Interactions with Methadone: Pharmacokinetics, Proceedings of expert workshop on the induction and stabilization of Patients on methadone. www.australiansplantauthorithy.gov.au.
Discussion Paper
Chen, WK., Berger,CC., Forde, DP., Adamo, DC., Weintrub, E., and Gandhi,D., (2011). Benzodiazepine use and misuse among patient in a methadone program. BMC Psychiatry. Biomed Central
Chouinard,G. (2004). Issues in the clinical use of the benzodiazepines potency.
Withdrawal ang rebound. Eur Neuropsychopharmacol
Dazord A, Mino A, Page D, dan Broers B. (1998). Patients on methadone maintenance treatment in Geneva. [Abstrak].Eur Psychiatry: 13: 235-241 Departemen Kesehatan Republik Indonesia. (2006). Keputusan Menteri
Kesehatan Republik Indonesia Nomor 494/Menkes/SK/ VII/ 2006 tentang Penetapan Rumah Sakit dan Satelit Uji Coba Pelayanan Terapi Rumatan Metadon serta Pedoman Program Terapi Metadon. Depkes RI: Jakarta.
Departemen Kesehatan RI, (2004). Perilaku Penggunaaan Terapi Rumatan Metadon. Jakarta.
Depertemen Kesehatan, (2007). Modul dan Kurikulum Program Terapi Rumatan Metadon. Jakarta.
Departemen Kesehatan. (2010). Jumlah Kumulatif AIDS di Indonesia 18.442 Kasus Http://www. Depkes,go.id/.
Depkes, (2009). Undang-Undang Republik Indonesia Nomor 35 Tahun 2009 Tentang Narkotika
Departemen Kesehatan Republik Indonesia. (2006). Keputusan Menteri Kesehatan Republik Indonesia No. 567/Menkes/SK/VIII/2006 tanggal 2 Agustus 2006. Pedoman Pelaksanaan Pengurangan Dampak Buruk Narkotika, Psikotropika, dan Zat Adiktif (Napza)
Dianawati, A (2014). Faktor Faktor Yang Mempengaruhi Retensi Pasien Program Terapi Rumatan Metadon ( PTRM ) Pada Puskesmas Kecamatan Di Jakarta. Fakultas Kedokteran.Universitas Gadjah Mada :Yogyakarta Dilla A, Ridwan A, Ansariadi . (2014). Relationship Between Behavioral Factors
With Retention Of Patient Methadone Maintenance Treatment Program In Kassi-Kassi Health Center. Bagian Epidemiologi Fakultas Kesehatan Masyarakat Universitas Hasanuddin
Drake S,Swift W,Hall W, dan Ross M. (1993). Drug use, HIV risk-taking and psychological correlates of benzodiazepine use among methadone maintenance clients.[Abstrak]. Drug Alcohol Depend: 34: 67-70.
Duma, (2012). Hubungan Pengetahuan, Sikap Dan Dukungan Keluarga Pengguna Narkoba Suntik Dengan Kepatuhan Berobat Ke Klinik Program Terapi Rumatan Metadon (Ptrm) Di Puskesmas Tanjung Morawa Kabupaten Deli Serdang. Universitas Sumatera Utara.
Edward, SH.et al (2003). Clinical Guidlines ang procedures for the use of methadone in the maintenence treatment of opioid dependence. Australian Government departement of health and ageing canberra.
Eunike Oktariana Depari, (2013). Dukungan Keluarga Dalam Pengobatan Pasien Rumatan Metadon Di Rsup H. Adam Malik Medan : Fakultas Keperawatan Universitas Sumatera Utara 2013
Eur, JC., Hallinan,R., Crettol,S., Agho,K., et al.,(2009). Cannabis and Benzodiazepines as determinants of methadone trough plasma concentration variability in maintenence treatment: a transnational study.
Pharmacokinetics and disposition
Fathollahi, SM., Torka, F., Najmeddin, N., and Rezaeian, M., (2016). Predictor Of One Year Retention In Methadone Maintenence Treatment (MMT) In Iran, Rafsanja. Zahedan university of medical sciences
Ferrari, A., Coccia, RPC., Bertolini, A., and Sternieri, E (2004). Methadone-Metabolism, Pharmacokinetics And Interaction. Section of toxicology and clinical pharmacology. University of modena and reggio emelia. Elsevier.
Pharmacologycal research
Hanasah N. (2010). Pengaruh obat Antiretroviral Lini Pertama Terhadap Dosis Metadon Pasien program terapi rumatan metadon di RSKO dan RSUP Fatmawati periode 2003-2009. FMIPA UI.
Hawari, D. (2002). Stress, Depresi dan Cemas. Jakarta, EGC : Halaman 39
Heikman, KP., Mohenen, HL., and Ojanpera, AL., (2017). Polydrug abuse among opioid maintenence treatment patients is related to inadequate dose of maintenence treatment medicine. BMC Psichiatry. BioMed
Huissod, T, Rousson, V, & Arber, FD, (2012). „Methadone Treatments in a Swiss Region, 2001-2008: a registry based analysis‟, BMC Psychiatry, 12
Humeniuk R, Ali R, White J, Hall W, dan Farrell M. (2000). Proceedings of Expert Workshop on the induction and Stabilisasation Onto methadone.
Monograph series No. 39. Commonwealth Department of Health and Aged Care: Adelaide, South Australia. Department of Health and Aged Care:Adelaide,SouthAustralia.(http://www.pherp.health.gov.au/internet/m ain/publishing.nsf/Content/87AFC56E26122571CA2570370007714F/$Fil e/mono39.pdf) didownload tanggal 27 januari 2017 McEvoy GK.(2004).
AHFS Drug Information 2004. Amer Soc of Health System
Hubbard R, Craddock S, Flynn P, Anderson J, dan Etheridge RM. (1997).
Overview of one-year follow up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychol Addict Behav. [Abstrak]. 11(4): 261-278.
Jenkins, AJ. Edward J. dan Cone, (1998). Pharmacokinetics: Drug Absorbstion, Distribution, and Elimination. Karch, S.B and William Meil, ed. .In Drug Abused Hand Book, Florida: CRC Press LLC.
Jiang H., Han Y., Du J.,et al . (2014). Faktor Associated With One Year Retention To Methadone Maintenence Treatment Program Among Patient With Heroin Dependence In China. Substance Abuse Treatment, Prevention And Policy.
Jonhnson,WK., Shamblen,RS., Couser, WM., Young, L., Abadi, HM., (2013).
Drug Use And Treatment Success Among Gang An Non Gang Member In El Salvador : A Prospective Cohor Study. Substance Abuse Treatment Prevention and Policy
Joseph, H., Stancliff S, dan Langrod,J. (2000). Methadone, Maintenance Treatment (MMT). A review of Historical and Clinical issues. [Abstrak].
Mt Sinai J Med. 67(5-6): 347-364.
Kementerian Koordinator bidang Kesejahteraan Rakyat Republik Indonesia.
(2007). Peraturan Menteri Koordinator bidang Kesejahteraan Rakyat Republik Indonesia Nomor 02/Per/Menko/Kesra/I/2007 tentang Kebijakan Nasional Penanggulangan HIV dan AIDS melalui pengurangan Dampak Buruk Penggunaan NAPZA suntik.
Kosten, Thomas R. and P. George. (2002). The Neurobiology of Opiod Dependence : Implication for Treatment, Research Reviews -The Neurobiology of Opioid Dependence.
Kristensen K, Christensen CB, dan Christrup L L. (1995). The μ1, μ2, δ, χ opioid receptor binding profiles of methadone stereoisomers and morphine.[abstract]. Life Sci : 56: 45-50.
Kristensen K, Christensen CB, dan Christrup LL. (1995). The μ1, μ2, δ, χ opioid receptor binding profiles of methadone stereoisomers and morphine.[abstract]. LifeSci : 56: 45-50.
Lee FJ., Lo MS., Chang HY., Lee SY., Lu RB. (2017). Faktor Associated Eith Retention In A Methadone Maintenence Treatment Program In Heroin-Dependent Han Chinese In Taiwan. Neuropsychiatry .London
Lee,YH.,Li, HJ., Wu,TL,. Wu, SJ., Yen, FC., and Tang, PH , (2012). Survey Of Methadone –Drug Interaction Among Patients Of Methadone Maintenence Treatment Program In Taiwan. Substance abuse treatment, prevention, and policy. Biomed Central
Liu, E, Liang, T, Shen, L, Zhong, H, & Wang, B, 2009, „Correlates of Methadone Client Retention: A Prospective Cohort Study in Guizhou Province, China‟. NIH Public Access.
Luscher, Christian, (2007), Drug of Abuse. In Basic & Clinical Pharmacology, 10th ed., Katzung BG. Ed., New York: McGraw-Hill Company, 2007.
Mahmood SF.,Fateme .,Hamid N., and Mohsen R. (2016). Predictor of One Years Retention in Methadone Maintenence Treatment (MMT) in Iran, Rafsanja.
High Risk Behav Addict Iran
Menkes, (2015). Pedoman Nasional Pelayanan Kedokteran Jiwa (Psikiatri).
Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.02.02/MENKES/73/2015. Jakarta
Menkes RI. (1979). Farmakope Indonesia Edisi III. Departemen Kesehatan RI:
Jakarta. Halaman 975.
Metzger DS, Woody GE, McLellan AT, O‟Brien CP, Druley P, et al. (1993).
Human Immunodeficiency virus seroconversion among intravenous drug users in and out of treatment: an 18 month prospective follow up. J Acquir Immune Defic Syndr.6(9): 1049-1056
Mohamad, N, Hidayah, N, Musa, N, Talib, N, and Ismail, R, (2010). „Better Retention of Malaysian Opiate Dependents Treated with High Dose Methadone in Methadone Maintenance Therapy‟, Harm Reduction Journal National Treatment Agency for Substance Misuse (2005). Methadone Dose and
Methadone Maintenance treatment.
National Institute of Health/ NIH (2009). Principles of Drug Addiction Treatment
A research based guide. Second edition.
(http://www.drugabuse.gov/PDF/PODAT/PODAT.pdf).
New South Wales Departement of Health/NSW. (2006). New South Wales Opioid Treatment Program Guidelines: Clinical Studies for Methadone and
Buphrenorphine treatment of opioid
dependence.(http://www.health.nsw.gov.au/policies/gl/2006/pdf/GL2006_
019.pdf) didownload tanggal 18 Januari 2017
Novick, DM. (2000). The impact of Hepatitis C Virus Infection on Methadone Maintenance Treatment. The Mount Sinai Journal of Medicine, 67(5&6).pp.437- 443.
Pahlemy Helsy (2010). Hubungan Dosis dan Retensi Pada Terapi Rumatan Metadon Multiepisode DiRumah Sakit Ketergantungan Obat Jakarta Dan Rumah Sakit Umum Pusat Fatmawati . Universitas Indonesia.
Pelatihan Program Terapi Rumatan Metadon (PTRM). Jakarta. Departemen Kesehatan. (2006). Pedoman Program Terapi Rumatan Metadon, Lampiran Kepmenkes No. 499/Menkes/SK/VII/ 2006
Peraturan Menteri Kesehatan Republik Indonesia (PerMenKes RI) Nomor 57 (2013). Tentang Pedoman Penyelenggaraan Program Terapi Rumatan Metadon. Jakarta
Phallyka C. (2012). Propective cohort study of factors associated with retention of menthadone maintenence therapy among patient at the center for menta haelth and drug dependence in cambodia. Thesis prsented to the highger degree committe. Graduate of ritsumeikan asia pacific university.
Powers,K.I. dan Anglin, M.D. (1998). A Differential assessment of the cumulative versus stabilizing effect of methadone maintenance treatment. Abstract.
Eval Rev : 22(2):175-206.
Purba (2010). Asuhan Keperawatan pada Klien dengan Masalah Psikososial dan Gangguan Jiwa. Medan : USU Press.
Rahayu, T (2013), „Gambaran dan faktor-faktor yang berhubungan dengan retensi pasien program terapi rumatan metadon (PTRM) di Puskesmas Kecamatan Tebet‟ Skripsi, Universitas Indonesia, Jakarta
Sadock, BJ., Sadock, JA.,(2015) Opioid -Related Disorder . Kaplan dan Sadock‟s Synopsis of Psychiatry Behavioral Science/Clinical Psychiatry, 10th Ed.
Wolters Kluwer, Lippincott Williams dan Wilkins, Philadelphia
Sarasvita, R 2009, „Treatment Retention in Methadone Maintenance Program in Indonesia: Toward Evidence-Informed Drug Policy‟, Thesis, University of Adelaide.
Susilowati I .(2013). Gambaran Dan Faktor Faktor Yang Berhubungan Dengan Retensi Pasien Program Terapi Rumatan Metadon (PTRM) Di Puskesmas Kecamatan Tebet. FKM. UI
Sweetman SC, Blake PS., McGlashan JM., Neathercoat GC, Parsons AV. (2007).
Martindale: The Complete Drug Reference 35th ed (2).
The College of Phycisians and Surgeon of Ontaria, (2005). Methadone Maintenance Guidelines, Ontario.
Undang-Undang Republik Indonesia Nomor 35 Tahun 2009 Tentang Narkotika Vafaeinasab, M.R.,Farahjadi,M.H.,Razaghi, O.M., Fallahzadeh,R.A.,Lotfi, M.H.,
and Akhondzadeh, S. (2015). Investigation Of Effecting Factors On Persistence Inthe Treatment Of Patient Under Methadone Maintenence Therapy In Addiction Therapy Center, Yazd Iran. Scientific Research Publishing
Vendramin, Andrea. (2009). Pharmacology and Neurochemistry of Methadone, Heroin addict Relat Clin Probl, 11(3): 11-28
Ward J,et al (1998). An evaluation of private methadone clinics. In Methadone Maintenance treatment and othe opioid replacement therapies. Harwood academic publisher: Amsterdam
Ward, Hall dan Mattick, (1995). An evaluation of private methadone clinics. In Methadone Maintenance treatment and othe opioid replacement therapies. Harwood academic publisher: Amsterdam
White dan Jason M, (1999). Drug Interactions with Methadone:
Pharmacodynamics. In Proceedings of Expert Workshop on the Induction and Srabilisation of Patients onto Methadone.
http://www.australianplanauthorithy.gov/au/
World Health Organization. (2008). WHO/UNDOC/UNAIDS position paper : Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention.
World Health Organization. (2009). Guidelines for Psychosocially Assisted Pharmacological Treatment of Opioid Dependence. Geneva: DC:
Author
World Health Organozation. (2008), Operational Guideline for the Management of Opioid Dependence in South East Asia Region. New Delhi, DC: Author.
World Health Organization. (1996). Cancer Pain Relief: With a Guide to Opioid Availability.Geneva.(http://whqlibdoc.who.int/publications/9241544821.p df) Tanggal 03 jan 2017
World Health Organization. (2015). The ICD-10 Classification of Mental and Behavioural Disorders: Clinical descriptions and diagnostic guidelines Wodak, Alex, (2001). Drug Treatment for Opioid Dependence, Auatralian
Prescriber, Vol 24 No 1. 2002.
Yang F., Lin P., Li Y., He Q., Long Q., Fu X., and Luo Y. (2013). Predictor Of Retension In Comunitity- Based Methadone Maintenence Treatment Program In Pearl River Delta China. Harm Reduction Journal
Zevin Shoshana and Benowitz Neal L. (1998), In Drug Abused Hand Book, Florida: CRC Press LLC.
Zanis DA dan Woody GE.(1998). One-year mortality rates following methadone treatment discharge. [Abstrak]. Drug Alcohol depend: 52(3): 257-260
lampiran 1. Persetujuan Kode Etik
Lampiran 2. Lembaran Persetujuan
Lampiran 3. Gambar obat metadon
Lampiran 4. Gambar Alat test pengujian drug urine screen
Lampiran 5. Gambar Hasil Pengujian drug urine screen
Pasien : N Positif : THC
Pasien : MD
Positif : AMP, MET, THC
Lampiran 6. Gambar pasien yang meminum metadon
Lampiran 7. Data statistik SPSS Distribusi Frekuensi
Berdasarkan Jenis kelamin
N Valid 66
Missing 0
Percentiles 25 2.0000
50 2.0000
75 2.0000
Frequency Percent Valid Percent
Cumulative Percent
Valid laki-laki 66 100.0 100.0 100.0
Berdasarkan usia
N Valid 66
Missing 0
Percentiles 25 1.0000
50 1.0000
75 2.0000
Usia Pasien
Frequency Percent Valid Percent
Cumulative Percent
Valid 25-35tahun 47 71.2 71.2 71.2
>35tahun 19 28.8 28.8 100.0
Total 66 100.0 100.0
status pernikahan
Frequency Percent Valid Percent
Cumulative
Frequency Percent Valid Percent
Cumulative
Berdasarkan pekerjaan
Frequency Percent Valid Percent
Cumulative
Frequency Percent Valid Percent
Cumulative
Berdasarkan Jarak Pelayanan
N Valid 66
Missing 0
Mean 1.6061
jarak
Frequency Percent Valid Percent
Cumulative
THD
Frequency Percent Valid Percent
Cumulative
Frequency Percent Valid Percent
Cumulative
Statistic Statistic Statistic Statistic Statistic Std. Error Statistic Statistic
Dosis terkecil 66 164.00 1.00 165.00 47.9091 4.26695 34.66487 1201.653
Valid N (listwise) 66
Berdasarkan riwayat dosis
Std. Error of Skewness .295
Kurtosis -.399
Std. Error of Kurtosis .582
Percentiles 25 2.0000
50 2.0000
75 2.0000
riwayat dosis
Frequency Percent Valid Percent
Cumulative
Statistic Statistic Statistic Statistic Statistic Std. Error Statistic Statistic Dosis Terbesar 66 183.00 2.00 185.00 63.4697 4.88355 39.67414 1574.038 Valid N (listwise) 66
Pengaruh dosis * RETENSI 1 TAHUN Crosstabulation
Linear-by-Linear Association 6.679 1 .010
N of Valid Cases 66
a. 2 cells (33,3%) have expected count less than 5. The minimum expected count is 3,48.
Berdasararkan dosis terlewatkan
Frequency Percent Valid Percent
Cumulative
Chi-Square Tests dosis yang terlewatkan
a. 2 cells (33,3%) have expected count less than 5. The minimum expected count is ,38.
Pengaruh penggunaan opioid lain terhadap retensi
Chi-Square Tests AMP
Continuity Correctionb .119 1 .730
Likelihood Ratio .555 1 .456
Fisher's Exact Test .686 .360
Linear-by-Linear Association .552 1 .458
N of Valid Cases 39
a. 2 cells (50,0%) have expected count less than 5. The minimum expected count is 3,08.
b. Computed only for a 2x2 table
Chi-Square Tests MET
Continuity Correctionb .712 1 .399
Likelihood Ratio 1.603 1 .206
Fisher's Exact Test .323 .195
Linear-by-Linear Association 1.736 1 .188
a. 1 cells (25,0%) have expected count less than 5. The minimum expected count is 1,64.
b. Computed only for a 2x2 table
Chi-Square Tests THC
Continuity Correctionb .019 1 .890
Likelihood Ratio .433 1 .510
Fisher's Exact Test 1.000 .470
Linear-by-Linear Association .386 1 .534
N of Valid Cases 39
a. 1 cells (25,0%) have expected count less than 5. The minimum expected count is 1,64.
b. Computed only for a 2x2 table
Chi-Square Tests BZO
Continuity Correctionb .094 1 .759
Likelihood Ratio .542 1 .461
Fisher's Exact Test .686 .389
Linear-by-Linear Association .506 1 .477
N of Valid Cases 39
a. 1 cells (25,0%) have expected count less than 5. The minimum expected count is 2,87.
b. Computed only for a 2x2 table